Abstract
Background: Many patients with paroxysmal atrial fibrillation (AF) become refractory to antiarrhythmic drugs (AADs). Early studies suggested that linear catheter ablation in the right atrium may provide sufficient substrate modification to reestablish therapeutic efficacy of previously ineffective AADs.
Methods: This prospective before-after multicenter trial evaluated the safety and effectiveness of hybrid therapy that included right atrial catheter ablation coupled with a regimen of previously ineffective AADs on AF episode frequency and symptoms in drug refractory patients with paroxysmal AF. A standard linear lesion set (lateral, septal, isthmus) was used in all subjects. AF episode frequency, clinical arrhythmia symptoms, condition-specific (AFSS) and global health-related quality of life (SF-36) were assessed prior to ablation and at 6 months.
Results: Ninety-three subjects, refractory to an average 2.9 AADs at baseline, qualified for inclusion and underwent right atrial catheter ablation. Eighty-four subjects (90%) provided 6 month AF episode frequency data which demonstrated a significant decrease compared to baseline (3.4 vs. 9.5, p < 0.0001). Forty-nine subjects (58%) were considered a clinical success by virtue of achieving a pre-specified target level episode frequency reduction of 50% or greater. Substantial and statistically significant improvements were realized almost uniformly for all measured arrhythmia symptoms as well as for both quality of life measures. The incidence of major complications was 5.4%.
Conclusions: The addition of right atrial catheter ablation to a regimen of previously ineffective AADs is associated with a significant reduction in the frequency, duration and severity of AF episodes and symptoms.
Similar content being viewed by others
References
Narayan SM, Cain ME, Smith JM. Atrial fibrillation. Lancet1997;350:943–950.
Cox JL, Schuessler RB, Lappas DG, Boineau JP. An 8 1/2-year clinical experience with surgery for atrial fibrillation. Ann Surg1996;224:267–273; discussion 273– 265.
Lonnerholm S, Blomstrom P, Nilsson L, Oxelbark S, Jideus L, Blomstrom-Lundqvist C. Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation2000;101:2607–2611.
Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A; American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: Executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol2001;38:1231–1266.
Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: Implications for optimal patient care. J Am Coll Cardiol2004;43:47– 52.
Snow V, Weiss KB, LeFevre M, McNamara R, Bass E, Green LA, Michl K, Owens DK, Susman J, Allen DI, Mottur-Pilson C; AAFP Panel on Atrial Fibrillation; ACP Panel on Atrial Fibrillation. Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med2003;139:1009–1017.
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med2002;347:1825–1833.
Keane D, Zhou L, Ruskin J. Catheter ablation for atrial fibrillation. Semin Interv Cardiol1997;2:251–265.
Keane D, Zou L, Ruskin J. Nonpharmacologic therapies for atrial fibrillation. Am J Cardiol1998;81:41C– 45C.
Ng FS, Camm AJ. Catheter ablation of atrial fibrillation. Clin Cardiol2002;25:384–394.
Adam M, Fischetti D, Montenero AS. A typical pattern of activation in the right atrium during paroxysmal atrial fibrillation: The washing-machine phenomenon. Cardiol 1999;44:63–68.
Allessie MA, Konings K, Kirchhof CJ, Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol1996;77:10A–23A.
Nair M, Shah P, Batra R, Kumar M, Mohan J, Kaul U, Arora R. Chronic atrial fibrillation in patients with rheumatic heart disease: Mapping and radiofrequency ablation of flutter circuits seen at initiation after cardioversion. Circulation2001;104:802–809.
Schmitt C, Ndrepepa G, Weber S, Schmieder S, Weyerbrock S, Schneider M, Karch MR, Deisenhofer I, Schreieck J, Zrenner B, Schomig A. Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation. Am J Cardiol2002;89:1381–1387.
Saksena S, Prakash A, Krol RB, Shankar A. Regional endocardial mapping of spontaneous and induced atrial fibrillation in patients with heart disease and refractory atrial fibrillation. Am J Cardiol1999;84:880–889.
Jais P, Weerasooriya R, Shah DC, Hocini M, Macle L, Choi KJ, Scavee C, Haissaguerre M, Clementy J. Ablation therapy for atrial fibrillation (AF): Past, present and future. Cardiovasc Res2002;54:337–346.
Calkins H, Hall J, Ellenbogen K, Walcott G, Sherman M, Bowe W, Simpson J, Castellano T, Kay GN. A new system for catheter ablation of atrial fibrillation. Am J Cardiol1999;83:227D–236D.
Kocheril AG. Right atrial mapping and linear ablation for paroxysmal atrial fibrillation. J Interv Card Electrophysiol2001;5:505–510.
Murgatroyd FD. “Pills and pulses”: Hybrid therapy for atrial fibrillation. J Cardiovasc Electrophysiol2002;13:S40–S46.
Santini M, Pignalberi C, Ricci R, Calo L. Hybrid therapy of atrial fibrillation. Ital Heart J2002;3:571–578.
Block JE, Kocheril A. Right atrial ablation in the management of atrial fibrillation: Point of view. J Interv Card Electrophysiol2004;16.
Jumrussirikul P, Atiga WL, Lardo AC, Berger RD, Halperin H, Hutchins GM, Calkins H. Prospective comparison of lesions created using a multipolar microcatheter ablation system with those created using a pullback approach with standard radiofrequency ablation in the canine atrium. Pacing Clin Electrophysiol2000;23:203–213.
Kocheril A. Revelation(R) Tx Microcatheter Maze Procedure Successfully Treats Paroxysmal AF. Pacing Clin Electrophysiol2003;26:1566.
Ware JE, Jr., Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol1998;51:903–912.
Ware JE, Jr., Snow KK, Kosinski M, Gandek B. Validity: Norm-based interpretation. SF-36 Health Survey Manual and Interpretation Guide. Vol 10. Lincoln, RI: Quality Metric, Inc.; 2000:4–10.
Braunwald E. Shattuck lecture–cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities. N Engl J Med1997;337:1360–1369.
Gaita F, Riccardi R, Calo L, Scaglione M, Garberoglio L, Antolini R, Kirchner M, Lamberti F, Richiardi E. Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Electrophysiological findings and ablation results. Circulation1998;97:2136–2145.
Garg A, Finneran W, Mollerus M, Birgersdotter-Green U, Fujimura O, Tone L, Feld GK. Right atrial compartmentalization using radiofrequency catheter ablation for management of patients with refractory atrial fibrillation. J Cardiovasc Electrophysiol1999;10:763–771.
Calo L, Lamberti F, Loricchio ML, Castro A, Shpun S, Boggi A, Pandozi C, Santini M. Long-term follow-up of right atrial ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol2004;15:37–43.
Montenero AS, Quayyum A, Franciosa P, Mangiameli D, Antonelli A, Barbieri L, Bruno N, Zumbo F, Vimercati M. Implantable loop recorders: A novel method to judge patient perception of atrial fibrillation. Preliminary results from a pilot study. J Interv Card Electrophysiol2004;10:211–220.
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Jama1995;273:408–412.
Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med2000;342:1878–1886.
Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med2000;342:1887–1892.
Bouchet C, Guillemin F, Briancon S. Nonspecific effects in longitudinal studies: Impact on quality of life measures. J Clin Epidemiol1996;49:15–20.
Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagne P, Nattel S, Thibault B. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med2000;342:913–920.
Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med1998;339:659–666.
Arentz T, von Rosenthal J, Blum T, Stockinger J, Burkle G, Weber R, Jander N, Neumann FJ, Kalusche D. Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation. Circulation2003;108:2484–2490.
Ernst S, Ouyang F, Lober F, Antz M, Kuck KH. Catheter-induced linear lesions in the left atrium in patients with atrial fibrillation: An electroanatomic study. J Am Coll Cardiol2003;42:1271–1282.
Nanthakumar K, Plumb VJ, Epstein AE, Veenhuyzen GD, Link D, Kay GN. Resumption of electrical conduction in previously isolated pulmonary veins: Rationale for a different strategy? Circulation2004;109:1226–1229.
Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, Salvati A, Dicandia C, Mazzone P, Santinelli V, Gulletta S, Chierchia S. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation2000;102:2619–2628.
Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, Salvati A, Dicandia C, Calabro MP, Mazzone P, Ficarra E, Di Gioia C, Gulletta S, Nardi S, Santinelli V, Benussi S, Alfieri O. Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: Efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation2001;104:2539–2544.
Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J Cardiovasc Electrophysiol2001;12:900–908.
Jais P, Shah DC, Hocini M, Yamane T, Haissaguerre M, Clementy J. Radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol2000;11:758– 761.
Yu WC, Hsu TL, Tai CT, Tsai CF, Hsieh MH, Lin WS, Lin YK, Tsao HM, Ding YA, Chang MS, Chen SA. Acquired pulmonary vein stenosis after radiofrequency catheter ablation of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol2001;12:887–892.
Kok LC, Mangrum JM, Haines DE, Mounsey JP. Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol2002;13:764–767.
Saad EB, Rossillo A, Saad CP, Martin DO, Bhargava M, Erciyes D, Bash D, Williams-Andrews M, Beheiry S, Marrouche NF, Adams J, Pisano E, Fanelli R, Potenza D, Raviele A, Bonso A, Themistoclakis S, Brachmann J, Saliba WI, Schweikert RA, Natale A. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: Functional characterization, evolution, and influence of the ablation strategy. Circulation2003;108:3102– 3107.
Arentz T, Jander N, von Rosenthal J, Blum T, Furmaier R, Gornandt L, Josef Neumann F, Kalusche D. Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J2003;24:963–969.
Pappone C, Oral H, Santinelli V, Vicedomini G, Lang CC, Manguso F, Torracca L, Benussi S, Alfieri O, Hong R, Lau W, Hirata K, Shikuma N, Hall B, Morady F. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation2004;109:2724–2726.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kocheril, A.G., Calkins, H., Sharma, A.D. et al. Hybrid Therapy with Right Atrial Catheter Ablation and Previously Ineffective Antiarrhythmic Drugs for the Management of Atrial Fibrillation. J Interv Card Electrophysiol 12, 189–197 (2005). https://doi.org/10.1007/s10840-005-0620-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10840-005-0620-7